Gritstone Oncology, Inc. announced changes to its board of directors. Elaine V. Jones, Ph.D., has joined the company’s board, replacing Peter Svennilson, founder of the Column Group and co-lead Series A investor in Gritstone. Dr. Jones was most recently vice president, worldwide business development and senior partner at Pfizer Ventures. During her tenure from 2008 to 2019, Dr. Jones was responsible for managing biotechnology and healthcare investments for Pfizer, as well as serving on the board of directors for several biotechnology companies. She received a B.S. in biology from Juniata College and a Ph.D. in microbiology from the University of Pittsburgh.